Literature DB >> 1591994

Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development.

R Wang1, R Clark, V L Bautch.   

Abstract

Murine embryonic stem cells can differentiate in vitro to form cystic embryoid bodies (CEB) that contain different structures and cell types. The blood islands are one such structure that consist of immature hematopoietic cells surrounded by endothelial cells, the first identifiable vascular cells. CEBs differentiated in vitro developed blood islands initially, and subsequently these blood islands matured to form vascular channels containing hematopoietic cells. Phase contrast microscopy demonstrated the presence of channels in mature CEBs grown in suspension culture, and high resolution light and electron microscopy showed that the cells lining these channels were endothelial cells. The channels appeared less organized than the vasculature of the mature yolk sac. The hematopoietic cells were occasionally seen 'flowing' through the CEB channels, although their numbers were reduced relative to the yolk sac. Analysis of primary CEB cultures showed the presence of cells with two characteristics of endothelial cells: approximately 30% of the cells labelled with fluorescent acetylated low density lipoprotein and a small number of cells were positive for von Willebrand's factor by immunostaining. Thus we conclude that a primitive vasculature forms in CEBs differentiated in vitro, and that not only primary differentiation of endothelial cells but also some aspects of vascular maturation are intrinsic to this cell culture system. CEBs are therefore a useful model for the study of developmental blood vessel formation.

Entities:  

Mesh:

Year:  1992        PMID: 1591994     DOI: 10.1242/dev.114.2.303

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  44 in total

1.  Gene trap vector screen for developmental genes in differentiating ES cells.

Authors:  Heidi Stuhlmann
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells.

Authors:  Yaxu Wu; Martin Moser; Victoria L Bautch; Cam Patterson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 3.  Embryonic stem cells.

Authors:  H J Rippon; A E Bishop
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

Review 4.  How blood vessel networks are made and measured.

Authors:  John C Chappell; David M Wiley; Victoria L Bautch
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

5.  Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development.

Authors:  Jean J Latimer; Roger A Pedersen
Journal:  Mod Cell Biol       Date:  1993

6.  Induction of lymphatic endothelial cell differentiation in embryoid bodies.

Authors:  Ruediger Liersch; Filip Nay; Lingge Lu; Michael Detmar
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

Review 7.  In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.

Authors:  Anne M Goodwin
Journal:  Microvasc Res       Date:  2007-06-06       Impact factor: 3.514

8.  The Centre for Modeling Human Disease Gene Trap resource.

Authors:  Christine To; Trevor Epp; Tammy Reid; Qing Lan; Mei Yu; Carol Y J Li; Minako Ohishi; Paula Hant; Nora Tsao; Guillermo Casallo; Janet Rossant; Lucy R Osborne; William L Stanford
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

9.  Endothelial differentiation of embryonic stem cells.

Authors:  Alicia A Blancas; Nicholas E Lauer; Kara E McCloskey
Journal:  Curr Protoc Stem Cell Biol       Date:  2008-09

10.  Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice.

Authors:  W C Aird; N Jahroudi; H Weiler-Guettler; H B Rayburn; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.